Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2021 Filed Jun 12, 2021 00:22 UTC |
Friedman BartDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-21-040075 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 12, 2021 00:15 UTC |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-21-040069 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-10 F1 · derivative.exercise_date: The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 02, 2021 Filed Jun 10, 2021 23:49 UTC |
Rona Jeffrey AChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-21-039670 · doc4.xml · derivative · entry 1 Rona Jeffrey A · CIK 0001311404 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-06-01 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on June 2, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 00:57 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-033828 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2031-05-16 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 17, 2021 Filed May 18, 2021 21:04 UTC |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-033831 · doc4.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2031-05-16 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 01:00 UTC |
Friedman BartDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-033829 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2031-05-16 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 00:51 UTC |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,750 | $0.00 Strike: $3.67 | $0.00 |
DisclosureSEC source: 0001209191-21-033825 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2031-05-16 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 01:27 UTC |
Tardio JasonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001209191-21-008642 · doc4.xml · derivative · entry 1 Tardio Jason · CIK 0001794698 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-06-19 F1 · balance_after: On June 19, 2020, the reporting person was granted an option for 175,000 shares of common stock. The option vests in three tranches based on the satisfaction of certain performance criteria. The performance criteria for the second tranche was met and approved on 2/5/2021, resulting in the vesting of 75,000 shares. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 16:38 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064649 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:45 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 650,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064657 · doc4.xml · derivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:58 UTC |
Rona Jeffrey AChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064666 · doc4.xml · derivative · entry 1 Rona Jeffrey A · CIK 0001311404 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 16:34 UTC |
Daly TimothyEVP,Finance & Corp. Controller
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064645 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · EVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:08 UTC |
Tardio JasonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064678 · doc4.xml · derivative · entry 1 Tardio Jason · CIK 0001794698 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:04 UTC |
Perone Thomas MichaelGeneral Counsel, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064674 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 21:53 UTC |
Rakhit AmitPresident and CMO
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001209191-20-064665 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| November 25, 2020 Filed Apr 29, 2021 21:32 UTC |
Perone Thomas MichaelGeneral Counsel, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 44,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001209191-21-029048 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2030-05-04 F1 · derivative.exercise_date: On May 5, 2020, the Reporting Person was granted the option to purchase shares of the Issuer's common stock, subject to a performance-based vesting condition to be satisfied upon the achievement of a particular milestone related to the Issuer's clinical trial, and further subject to the Reporting Person's continuous service through such vesting date. Such option vested in full on November 25, 2020 upon the satisfaction of such performance-based vesting condition. Read SEC document |
| November 25, 2020 Filed Apr 29, 2021 21:30 UTC |
Tardio JasonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,000 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001209191-21-029041 · doc4.xml · derivative · entry 1 Tardio Jason · CIK 0001794698 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2030-05-04 F1 · derivative.exercise_date: On May 5, 2020, the Reporting Person was granted the option to purchase shares of the Issuer's common stock, subject to a performance-based vesting condition to be satisfied upon the achievement of a particular milestone related to the Issuer's clinical trial, and further subject to the Reporting Person's continuous service through such vesting date. Such option vested in full on November 25, 2020 upon the satisfaction of such performance-based vesting condition. Read SEC document |
| October 11, 2020 Filed Oct 13, 2020 16:41 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantStock option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001209191-20-054645 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-10-10 F1 · derivative.exercise_date: 50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date. Read SEC document |
| October 11, 2020 Filed Oct 13, 2020 20:46 UTC |
Rona Jeffrey AChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001209191-20-054653 · doc4.xml · derivative · entry 1 Rona Jeffrey A · CIK 0001311404 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-10-10 F1 · derivative.exercise_date: 50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date. Read SEC document |
| October 11, 2020 Filed Oct 13, 2020 20:38 UTC |
Perone Thomas MichaelGeneral Counsel, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001209191-20-054642 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-10-10 F1 · derivative.exercise_date: 50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date. Read SEC document |
| September 30, 2020 Filed Oct 3, 2020 01:40 UTC |
Rona Jeffrey AChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 325,000 | $0.00 Strike: $5.74 | $0.00 |
DisclosureSEC source: 0001209191-20-053411 · doc4.xml · derivative · entry 1 Rona Jeffrey A · CIK 0001311404 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,000 Underlying: Common Stock · 325,000 shares Expires 2030-09-29 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on September 30, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| August 28, 2020 Filed Sep 2, 2020 01:34 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
PurchaseCommon Stock | 8,488 | $5.84 | $49,569.92 |
DisclosureSEC source: 0001209191-20-049011 · doc4.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,792,530 Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:33 UTC |
Tardio JasonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001209191-20-038475 · doc4.xml · derivative · entry 1 Tardio Jason · CIK 0001794698 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-18 F1 · balance_after: On June 19, 2020, the reporting person was granted an option for 175,000 shares of common stock. The option vests in three tranches based on the satisfaction of certain performance criteria. The performance criteria for the first tranche was met on the date of grant, resulting in the vesting of 50,000 shares. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:37 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,250 | $0.00 Strike: $5.29 | $0.00 |
DisclosureSEC source: 0001209191-20-035039 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2030-06-04 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 17:39 UTC |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,250 | $0.00 Strike: $5.29 | $0.00 |
DisclosureSEC source: 0001209191-20-035041 · doc4.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2030-06-04 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:38 UTC |
Friedman BartDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,250 | $0.00 Strike: $5.29 | $0.00 |
DisclosureSEC source: 0001209191-20-035040 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2030-06-04 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:36 UTC |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,250 | $0.00 Strike: $5.29 | $0.00 |
DisclosureSEC source: 0001209191-20-035038 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,250 Underlying: Common Stock · 13,250 shares Expires 2030-06-04 F1 · derivative.exercise_date: The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 00:47 UTC |
Perone Thomas MichaelGeneral Counsel, Secretary
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001209191-20-000452 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · General Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-12-31 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 16:21 UTC |
Haasner DirkSVP, Global Regulatory Affairs
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-19-061548 · doc4.xml · derivative · entry 1 Haasner Dirk · CIK 0001704660 · SVP, Global Regulatory Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:24 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-19-061560 · doc4.xml · derivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 16:19 UTC |
Daly TimothyEVP,Finance & Corp. Controller
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-19-061544 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · EVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:29 UTC |
Rakhit AmitPresident and CMO
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-19-061568 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 21:18 UTC |
Perone Thomas MichaelSVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001209191-19-061538 · doc4.xml · derivative · entry 1 Perone Thomas Michael · CIK 0001771761 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-12-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 13:59 UTC |
Tardio JasonChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-19-057557 · doc4.xml · derivative · entry 1 Tardio Jason · CIK 0001794698 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-11-17 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on November 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:24 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (right to buy) · Derivative | 7,437 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001209191-19-056741 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 Underlying: Common Stock · 7,437 shares Expires 2029-11-12 F1 · derivative.exercise_date: The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 16:28 UTC |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (right to buy) · Derivative | 7,437 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001209191-19-056750 · doc4.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 Underlying: Common Stock · 7,437 shares Expires 2029-11-12 F1 · derivative.exercise_date: The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:26 UTC |
Friedman BartDirector
|
GrantStock Option (right to buy) · Derivative | 7,437 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001209191-19-056745 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 Underlying: Common Stock · 7,437 shares Expires 2029-11-12 F1 · derivative.exercise_date: The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:22 UTC |
Bernstein KarenDirector
|
GrantStock Option (right to buy) · Derivative | 7,437 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001209191-19-056735 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 Underlying: Common Stock · 7,437 shares Expires 2029-11-12 F1 · derivative.exercise_date: The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 17:43 UTC |
Daly TimothyEVP,Finance & Corp. Controller
|
GrantEmployee stock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055000 · doc4.xml · derivative · entry 1 Daly Timothy · CIK 0001535896 · EVP,Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-10-31 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on November 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 22:46 UTC |
Rakhit AmitPresident and CMO
|
GrantCommon Stock (right to buy) · Derivative | 75,000 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001209191-19-055002 · doc4.xml · derivative · entry 1 Rakhit Amit · CIK 0001704636 · President and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-10-31 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on November 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date. Read SEC document |
| October 08, 2019 Filed Oct 11, 2019 00:32 UTC |
LEVIN JEREMY MDirector · CEO · 10% owner
|
PurchaseCommon Stock | 60,000 | $2.50 | $150,000.00 |
DisclosureSEC source: 0001209191-19-052988 · doc4.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,736,529 F1 · price: Shares were purchased in a Public Offering of the Issuer at a public offering price of $2.50. Read SEC document |
| October 08, 2019 Filed Nov 22, 2019 06:23 UTC |
TAKEDA PHARMACEUTICAL CO LTD10% owner
MILLENNIUM PHARMACEUTICALS INC10% owner
|
PurchaseCommon Stock | 2,000,000 | $2.50 | $5,000,000.00 |
DisclosureSEC source: 0001395064-19-000083 · wf-form4_157442176475523.xml · nonDerivative · entry 1 TAKEDA PHARMACEUTICAL CO LTD · CIK 0001395064 · 10% owner MILLENNIUM PHARMACEUTICALS INC · CIK 0001002637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 5,750,000 F1 · ownership.nature: This statement is being filed jointly by Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. F2 · ownership.nature: Takeda Pharmaceutical Company Limited's beneficial ownership of the Issuer's Common Stock is comprised of 1,781,996 shares of Common Stock that it holds directly and 5,750,000 shares of Common Stock held directly by Millennium Pharmaceuticals, Inc., which is a direct, wholly owned subsidiary of Takeda Pharmaceuticals U.S.A. Inc., which is owned directly by both Takeda Pharmaceutical Company Limited (58.09%) and Takeda Pharmaceuticals International AG (41.91%). Takeda Pharmaceuticals International AG is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. Read SEC document |
| September 20, 2019 Filed Feb 14, 2024 21:15 UTC Amendment |
LEVIN JEREMY MDirector · CEO
|
GiftCommon Stock | 465,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-003721 · form4a-02142024_040202.xml · nonDerivative · entry 1 LEVIN JEREMY M · CIK 0001256153 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: The shares were transferred to two family trusts for the benefit of the Reporting Person's adult children as part of generational estate planning. These transfers were made for no consideration. The Reporting Person does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares. These transactions are being reported late due to an inadvertent administrative error. F2 · ownership.nature: Prior to the gift, the reportable securities were owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2019 Filed Aug 1, 2019 21:00 UTC Amendment |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001209191-19-044050 · doc4a.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-09 F1 · security: This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019. F2 · derivative.exercise_date: The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 10, 2019 Filed Aug 1, 2019 17:01 UTC Amendment |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001209191-19-044055 · doc4a.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-09 F1 · security: This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019. F2 · derivative.exercise_date: The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 10, 2019 Filed Aug 1, 2019 20:58 UTC Amendment |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001209191-19-044045 · doc4a.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-09 F1 · security: This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019. F2 · derivative.exercise_date: The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 10, 2019 Filed Aug 3, 2019 00:28 UTC |
Friedman BartDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001209191-19-044363 · doc4.xml · derivative · entry 1 Friedman Bart · CIK 0001368324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-09 F1 · derivative.exercise_date: The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:21 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001209191-19-035786 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 16:24 UTC |
WILLIAMS DOUGLAS EDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001209191-19-035795 · doc4.xml · derivative · entry 1 WILLIAMS DOUGLAS E · CIK 0001184847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:19 UTC |
Bernstein KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,813 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001209191-19-035784 · doc4.xml · derivative · entry 1 Bernstein Karen · CIK 0001654055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,813 shares Expires 2029-06-06 F1 · derivative.exercise_date: The option will vest in full on June 7, 2020, subject to the Reporting Person's continuous service through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.